Inspire Medical Systems (INSP) Competitors $184.88 +8.82 (+5.01%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends INSP vs. SOLV, SNN, PEN, GKOS, BLCO, PRCT, AXNX, NVST, NARI, and LIVNShould you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Envista (NVST), Inari Medical (NARI), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. Inspire Medical Systems vs. Solventum Smith & Nephew Penumbra Glaukos Bausch + Lomb PROCEPT BioRobotics Axonics Envista Inari Medical LivaNova Solventum (NYSE:SOLV) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends. Do insiders & institutionals believe in SOLV or INSP? 94.9% of Inspire Medical Systems shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts prefer SOLV or INSP? Solventum currently has a consensus target price of $68.00, indicating a potential downside of 0.57%. Inspire Medical Systems has a consensus target price of $233.58, indicating a potential upside of 26.35%. Given Inspire Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is SOLV or INSP more profitable? Inspire Medical Systems has a net margin of 4.37% compared to Solventum's net margin of 0.00%. Inspire Medical Systems' return on equity of 5.30% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A Inspire Medical Systems 4.37%5.30%4.58% Does the MarketBeat Community favor SOLV or INSP? Inspire Medical Systems received 186 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 61.31% of users gave Inspire Medical Systems an outperform vote while only 5.88% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes15.88%Underperform Votes1694.12% Inspire Medical SystemsOutperform Votes18761.31% Underperform Votes11838.69% Which has preferable valuation & earnings, SOLV or INSP? Solventum has higher earnings, but lower revenue than Inspire Medical Systems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventumN/AN/AN/AN/AN/AInspire Medical Systems$624.80M8.87-$21.15M$1.07172.78 Does the media refer more to SOLV or INSP? In the previous week, Solventum had 2 more articles in the media than Inspire Medical Systems. MarketBeat recorded 15 mentions for Solventum and 13 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.29 beat Solventum's score of 0.88 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 9 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryInspire Medical Systems beats Solventum on 12 of the 13 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Inspire Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INSP vs. The Competition Export to ExcelMetricInspire Medical SystemsSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$5.54B$4.41B$5.03B$19.87BDividend YieldN/A41.16%5.16%3.52%P/E Ratio172.7824.82135.4142.95Price / Sales8.8747.021,160.9719.16Price / CashN/A51.8733.5317.86Price / Book9.534.974.675.52Net Income-$21.15M$13.76M$119.07M$986.45M7 Day Performance6.91%-1.08%-1.83%0.45%1 Month Performance-9.08%0.58%-3.60%1.05%1 Year Performance34.11%50.91%31.66%24.67% Inspire Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INSPInspire Medical Systems4.91 of 5 stars$184.88+5.0%$233.58+26.3%+29.2%$5.28B$624.80M172.781,011Analyst UpgradePositive NewsGap UpSOLVSolventum1.804 of 5 stars$68.39+2.0%$68.00-0.6%N/A$11.58BN/A0.0022,000SNNSmith & Nephew2.1198 of 5 stars$25.22-1.2%N/A-1.4%$11.15B$5.55B0.0018,452PENPenumbra4.3167 of 5 stars$239.20+0.9%$227.92-4.7%+1.6%$9.18B$1.16B278.144,200Analyst ForecastInsider TradeGKOSGlaukos3.8428 of 5 stars$141.44-1.9%$134.55-4.9%+121.3%$7.80B$360.35M-46.83780Positive NewsBLCOBausch + Lomb2.7887 of 5 stars$19.39-0.8%$20.91+7.8%+23.2%$6.88B$4.15B0.0013,300PRCTPROCEPT BioRobotics1.5867 of 5 stars$92.70-0.9%$89.50-3.5%+180.7%$4.88B$136.19M0.00626AXNXAxonics3.2587 of 5 stars$70.98flat$71.00+0.0%N/A$3.63B$366.38M-591.45610News CoverageNVSTEnvista3.6426 of 5 stars$20.37+0.5%$20.71+1.7%-14.3%$3.49B$2.57B-2.6212,800NARIInari Medical3.255 of 5 stars$49.00-3.9%$58.89+20.2%-15.9%$2.98B$493.63M0.001,300Insider TradePositive NewsLIVNLivaNova4.1794 of 5 stars$50.05-2.6%$69.17+38.2%+6.8%$2.79B$1.15B119.172,900 Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Glaukos Alternatives Bausch + Lomb Alternatives PROCEPT BioRobotics Alternatives Axonics Alternatives Envista Alternatives Inari Medical Alternatives LivaNova Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:INSP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.